"Senior drug policy leaders from the Mekong region -Cambodia, China, Lao, Myanmar, Thailand and Viet Nam- are in Nay Pyi Taw, Myanmar with the United Nations Office on Drugs and Crime (UNODC) this week for a conference of the Mekong MOU on Drug Control to discuss the illicit drug situation in the region, and to negotiate a new strategic plan. The conference brings together the leadership of Mekong drug authorities and over 100 senior delegates and experts to consider the latest data, and for detailed discussions on drug law enforcement, justice, health and alternative development strategies and programmes, while reviewing the implementation of the last Mekong strategy that the countries agreed. "Illicit drug challenges are not only a national issue, and to ensure our recently announced drug policy succeeds we need to focus on the situation and implementation including with regional partners" said Myanmar Deputy Home Minister Major General Aung Soe. "This meeting is a step forward, allowing us to discuss issues and priorities with our neighbours and UNODC, including improving law enforcement cooperation and standards for community based drug treatment." He added, "A top priority for us (Myanmar) is a regional precursor strategy that will slow the supply of chemicals and pharmaceutical products into drug producing areas of the Golden Triangle." The Mekong has long been associated with the production and trafficking of illicit drugs, particularly heroin, but has undergone significant transformation in recent years. Opium and heroin production have recently declined, while organized crime have intensified production and trafficking of both low grade yaba methamphetamine and high purity crystal methamphetamine to alarming levels - several Mekong countries have already surpassed 2017 seizure totals only a few months into 2018, and Golden Triangle methamphetamine is being seized in high volumes in Australia, Japan, New Zealand, Malaysia, Indonesia. The shift to synthetics like methamphetamine is particularly difficult for countries to address due to the complexity of responding to remote and clandestine production that can be moved, but also due to the health impacts on drug users..."